| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3609355
Max Phase: Preclinical
Molecular Formula: C20H25N3
Molecular Weight: 307.44
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1
Standard InChI: InChI=1S/C20H25N3/c1-2-7-20-18(6-1)19(16-21-20)17-8-14-23(15-9-17)13-5-12-22-10-3-4-11-22/h1-4,6-7,10-11,16-17,21H,5,8-9,12-15H2
Standard InChI Key: RMTLXPZRUYAFBY-UHFFFAOYSA-N
Associated Targets(non-human)
Alpha-1b adrenergic receptor 2470 Activities
Alpha-1a adrenergic receptor 3346 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 307.44 | Molecular Weight (Monoisotopic): 307.2048 | AlogP: 4.24 | #Rotatable Bonds: 5 |
| Polar Surface Area: 23.96 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 10.13 | CX LogP: 3.73 | CX LogD: 1.06 |
| Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -0.88 |
References
| 1. Hayashi R, Ohmori E, Moriwaki M, Kumagai H, Isogaya M.. (2015) Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists., 25 (18): [PMID:26238322] [10.1016/j.bmcl.2015.07.046] |
Source
Source(1):